A Smarter Screen for Sleep Apnea Stimulation - Summary - MDSpire
Advertisement
A Smarter Screen for Sleep Apnea Stimulation
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation
To evaluate a clinical staging system for predicting response to hypoglossal nerve stimulation in obstructive sleep apnea patients, highlighting its potential clinical significance.
Key Findings:
69.7% of patients met response criteria post-implantation.
Median AHI decreased from 30.7 to 6.9, a median difference of -20.65 events/hour (95% CI, -24.50 to -17.45).
Four baseline factors associated with response: smaller neck circumference, BMI <30, preimplant AHI <30, and absence of comorbidities.
The staging system showed moderate discrimination with a C statistic of 0.68.
Interpretation:
The clinical staging system may help stratify patients for hypoglossal nerve stimulation, but findings need validation in independent cohorts, underscoring the importance of further research.
Limitations:
Retrospective and single-center study.
38.7% of implanted patients were excluded due to lack of postimplant sleep testing, potentially biasing results.
Cohort predominantly male and White, limiting generalizability.
Patient-reported outcomes and BMI were only measured at baseline.
Conclusion:
The study suggests that a clinical staging system can aid in predicting response to hypoglossal nerve stimulation, but further research is needed to confirm these findings and their implications for clinical practice.
